GSK vs RELY · P/E 13, $103.31B cap vs rev $948.0M
GlaxoSmithKline PLC ADR (GSK) versus Remitly Global Inc (RELY) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Remitly Global Inc (RELY) is a software - infrastructure company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported RELY revenue for 2026-06-30 was $948.0M. Net income was $255.0M. RELY currently screens at market cap $3.77B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. RELY currently screens at market cap $3.77B.
Not investment advice. Open the GSK and RELY stock pages for the full models.
Not investment advice.